A KAIST research team found that B cell and antibody responses initiated in tumor-draining lymph nodes, rather than T cells alone, are critical to the antitumor effects of anti-CTLA-4 therapy, opening ...

A single drug shrank or eliminated tumors in 43 of 102 patients with advanced head-and-neck cancer that had stopped ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Subscribe to our newsletter for ...

PYXS’ micvotabart pelidotin faces head & neck cancer competition, side effects and funding risk. See fall 2026 catalyst, ...

This guide for newly diagnosed patients provides key information to help you understand your options and have informed conversations with your oncologist. A diagnosis of head and neck cancer can bring ...

Medical imaging routinely used in cancer care may hold far more biological information than previously thought. An international study involving Umeå University guest professor Lukas Kenner shows that ...

A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...

A new study suggests that cannabis, the most commonly used illicit substance worldwide, is associated with an increased occurrence of head and neck cancer. A study from the USC Head and Neck Center, ...

Genetic ancestry plays a key role in determining the behavior of head and neck tumors and may help explain why African-American patients survive for half as long as their counterparts of European ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why immunotherapy works for some patients but not others. Two new studies, published ...